FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)

View source ↗

Summary

FDA approved lisdexamfetamine dimesylate as a generic version of Vyvanse under an Original Application (ANDA) from SpecGx LLC. The product is indicated for atte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)